UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 358

Sortiert nach

Discovery and development of the anticancer agent salinosporamide A (NPI-0052)

Bioorganic & medicinal chemistry, 2009-03, Vol.17 (6), p.2175-2180

2009

Link zum Volltext

Verfügbarkeit prüfen

Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma

Blood, 2008-02, Vol.111 (3), p.1654-1664

2008

Link zum Volltext

Verfügbarkeit prüfen

A novel vascular disrupting agent plinabulin triggers JNK-mediated apoptosis and inhibits angiogenesis in multiple myeloma cells

Blood, 2011-05, Vol.117 (21), p.5692-5700

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI‐0052 (marizomib) in a human plasmacytoma xenograft murine model

British journal of haematology, 2010-05, Vol.149 (4), p.550-559

2010

Link zum Volltext

Verfügbarkeit prüfen

Structure−Activity Relationship Studies of Salinosporamide A (NPI-0052), a Novel Marine Derived Proteasome Inhibitor

Journal of medicinal chemistry, 2005-06, Vol.48 (11), p.3684-3687

2005

Link zum Volltext

Verfügbarkeit prüfen

Proteasome Inhibition Activates Epidermal Growth Factor Receptor (EGFR) and EGFR-Independent Mitogenic Kinase Signaling Pathways in Pancreatic Cancer Cells

Clinical cancer research, 2008-08, Vol.14 (16), p.5116-5123

2008

Link zum Volltext

Verfügbarkeit prüfen

Myeloid cell leukemia-1 (Mc1-1) is a candidate target gene of hypoxia-inducible factor-1 (HIF-1) in the testis

Reproductive biology and endocrinology, 2012-12, Vol.10 (1), p.104-104

2012

Link zum Volltext

Verfügbarkeit prüfen

NPI-0052 Enhances Tumoricidal Response to Conventional Cancer Therapy in a Colon Cancer Model

Clinical cancer research, 2006-11, Vol.12 (22), p.6758-6764

2006

Link zum Volltext

Verfügbarkeit prüfen

Leaving Groups Prolong the Duration of 20S Proteasome Inhibition and Enhance the Potency of Salinosporamides

Journal of medicinal chemistry, 2008-11, Vol.51 (21), p.6711-6724

2008

Link zum Volltext

Verfügbarkeit prüfen

MicroRNAs downregulated following immune activation of rat testis

American journal of reproductive immunology (1989), 2017-06, Vol.77 (6), p.n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma

Blood, 2010-01, Vol.115 (4), p.834-845

2010

Link zum Volltext

Verfügbarkeit prüfen

Anti-TNF-α therapies: the next generation

Nature reviews. Drug discovery, 2003-09, Vol.2 (9), p.736-746

2003

Link zum Volltext

Verfügbarkeit prüfen

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib

Cancer cell, 2005-11, Vol.8 (5), p.407-419

2005

Link zum Volltext

Verfügbarkeit prüfen

Selective Activation of Liver X Receptors by Acanthoic Acid-Related Diterpenes

Molecular pharmacology, 2007-06, Vol.71 (6), p.1545-1553

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination

Investigational new drugs, 2012-12, Vol.30 (6), p.2303-2317

2012

Link zum Volltext

Verfügbarkeit prüfen

Enantioselective Synthesis of the Antiinflammatory Agent (−)-Acanthoic Acid

Journal of organic chemistry, 2001-12, Vol.66 (26), p.8843-8853

2001

Link zum Volltext

Verfügbarkeit prüfen

Effects of lipopolysaccharide-induced inflammation on hypoxia and inflammatory gene expression pathways of the rat testis

Basic and clinical andrology, 2018-11, Vol.28 (1), p.14-14, Article 14

2018

Link zum Volltext

Verfügbarkeit prüfen

Proteasome Inhibition Activates Epidermal Growth Factor Receptor (EGFR) and EGFR-lndependent Mitogenic Kinase Signaling Pathways in Pancreatic Cancer Cells

Clinical cancer research, 2008-08, Vol.14 (16), p.5116-5123

2008

Link zum Volltext

Verfügbarkeit prüfen

Localization of Toll-like receptors on epididymal epithelial cells and spermatozoa

American journal of reproductive immunology (1989), 2008-12, Vol.60 (6), p.541-555

2008

Link zum Volltext

Verfügbarkeit prüfen

Dual targeting of the proteasome regulates survival and homing in Waldenström macroglobulinemia

Blood, 2008-05, Vol.111 (9), p.4752-4763

2008

Link zum Volltext

Verfügbarkeit prüfen

Twenty-First-Century Spaces for Twenty-First-Century Learners: Where We Are, How We Got Here, and What Next

Scholarship and practice of undergraduate research, 2017-01, Vol.1 (2), p.12

2017

Link zum Volltext

Verfügbarkeit prüfen

Proteasome regulator marizomib (NPI-0052) exhibits prolonged inhibition, attenuated efflux, and greater cytotoxicity than its reversible analogs

The Journal of pharmacology and experimental therapeutics, 2011-05, Vol.337 (2), p.479

2011

Link zum Volltext

Verfügbarkeit prüfen

Specific and prolonged proteasome inhibition dictates apoptosis induction by marizomib and its analogs

Chemico-biological interactions, 2011-10, Vol.194 (1), p.58-68

2011

Link zum Volltext

Verfügbarkeit prüfen

Trypanocidal activity of β-lactone-γ-lactam proteasome inhibitors

Planta medica, 2012-01, Vol.78 (2), p.131

2012

Link zum Volltext

Verfügbarkeit prüfen

Proteasome Inhibitors Prevent Caspase-1-Mediated Disease in Rodents Challenged with Anthrax Lethal Toxin

The American journal of pathology, 2010-08, Vol.177 (2), p.735-743

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 358

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(326)
Mit Volltextzugriff
(329)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(173)
Life Sciences & Biomedicine
(149)
Animals
(125)
Humans
(96)
Mice
(61)
Biological And Medical Sciences
(59)
Male
(39)
Fundamental And Applied Biological Sciences. Psychology
(35)
Female
(34)
Immunology
(32)
Medical Sciences
(28)
Biochemistry & Molecular Biology
(24)
Drosophila
(23)
Cell Biology
(21)
Mutation
(19)
Rats
(19)
Fundamental Immunology
(18)
Immunobiology
(18)
Pharmacology & Pharmacy
(18)
Oncology
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(34)
The American Biology Teacher
(21)
Cellular Immunology
(20)
Neurobiology Of Disease
(11)
Cancer Research
(10)
Biology Of Reproduction
(9)
Genetics
(7)
Science
(7)
The Journal Of Experimental Medicine
(7)
The Journal Of Immunology
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Discovery and development of the anticancer agent salinosporamide A (NPI-0052)

Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma

A novel vascular disrupting agent plinabulin triggers JNK-mediated apoptosis and inhibits angiogenesis in multiple myeloma cells

Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI‐0052 (marizomib) in a human plasmacytoma xenograft murine model

Structure−Activity Relationship Studies of Salinosporamide A (NPI-0052), a Novel Marine Derived Proteasome Inhibitor

Proteasome Inhibition Activates Epidermal Growth Factor Receptor (EGFR) and EGFR-Independent Mitogenic Kinase Signaling Pathways in Pancreatic Cancer Cells

Myeloid cell leukemia-1 (Mc1-1) is a candidate target gene of hypoxia-inducible factor-1 (HIF-1) in the testis

NPI-0052 Enhances Tumoricidal Response to Conventional Cancer Therapy in a Colon Cancer Model

Leaving Groups Prolong the Duration of 20S Proteasome Inhibition and Enhance the Potency of Salinosporamides

MicroRNAs downregulated following immune activation of rat testis

Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma

Anti-TNF-α therapies: the next generation

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib

Selective Activation of Liver X Receptors by Acanthoic Acid-Related Diterpenes

Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination

Enantioselective Synthesis of the Antiinflammatory Agent (−)-Acanthoic Acid

Effects of lipopolysaccharide-induced inflammation on hypoxia and inflammatory gene expression pathways of the rat testis

Proteasome Inhibition Activates Epidermal Growth Factor Receptor (EGFR) and EGFR-lndependent Mitogenic Kinase Signaling Pathways in Pancreatic Cancer Cells

Localization of Toll-like receptors on epididymal epithelial cells and spermatozoa

Dual targeting of the proteasome regulates survival and homing in Waldenström macroglobulinemia

Twenty-First-Century Spaces for Twenty-First-Century Learners: Where We Are, How We Got Here, and What Next

Proteasome regulator marizomib (NPI-0052) exhibits prolonged inhibition, attenuated efflux, and greater cytotoxicity than its reversible analogs

Specific and prolonged proteasome inhibition dictates apoptosis induction by marizomib and its analogs

Trypanocidal activity of β-lactone-γ-lactam proteasome inhibitors

Proteasome Inhibitors Prevent Caspase-1-Mediated Disease in Rodents Challenged with Anthrax Lethal Toxin

Suchergebnisse filtern